Prestige Hospitality Ventures, Anand Rathi Share and Stock Brokers, 3 others SEBI’s nod for IPOs
These companies, which filed their preliminary IPO papers between January and April, obtained SEBI’s observations during the week, as per the update.
Latest News
US Stock Market LIVE Updates: Stock futures fluctuate mixed earnings reports
US Stock Market LIVE Updates: Stock futures edged higher on Wednesday (August 6) as investors assessed a fresh round of corporate earnings after a weak…
Eternal Block Deal: Antfin set to exit its second company in three days on Thursday
This will mark the second exit from Antfin this week after the Alibaba unit sold its remaining stake of just over 5% in payments aggregator…
Luxury housing defies slowdown in NCR; Gurugram hotspots pull 9% growth in H1 2025
Southern Peripheral Road and Dwarka Expressway lead sales surge; luxury segment now 27% of NCR’s housing market.
RITES Q1 Results: Railway PSU reports flat revenue and profit growth; declares dividend
RITES also declared its first interim dividend for financial year 2025-26, which was ₹1.30 per share. Record date for the dividend payout has been fixed…
Stocks end lower as RBI policy weighs, IT and pharma drag; Reliance, HDFC Bank limit losses
The benchmark BSE Sensex fell 166 points, or 0.21%, to end at 80,544, while the NSE Nifty 50 declined 75 points, or 0.30%, to settle…
Bajaj Auto warns of EV business hit in Q2 as rare earth magnets shortage bites
Bajaj Auto’s EV business outperformed, and now comprises of more than 20% of the company’s overall domestic revenue, in comparison to the early teens that…
HUDCO Q1 Results: Strong growth in core income, asset quality improves
98.59% of HUDCO’s loan book consists of loans given to the government and its agencies. The management has earlier spoken about its plans to have…
Krishna Medical Q1 results: Profit falls, margins narrow; FY6 outlook positive
Shares of KIMS Ltd ended up 0.3% at ₹743.40 on the BSE.
AstraZeneca to launch eculizumab in India this August for rare blood disorders
AstraZeneca Pharma India is set to launch Eculizumab (Soliris) in August 2025, targeting the treatment of rare blood disorders PNH and aHUS. The drug inhibits…